Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Public ClinicalTrials.gov record NCT01338025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Antiretroviral Strategy in Persistently Non-adherent Children, Adolescents, and Young Adults Who Are Failing HAART and Have the M184V Resistance Mutation.
Study identification
- NCT ID
- NCT01338025
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- Network
- Enrollment
- 33 participants
Conditions and interventions
Conditions
Interventions
- HAART regimen Drug
- 3TC or FTC monotherapy Drug
Drug
Eligibility (public fields only)
- Age range
- 8 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2011
- Primary completion
- Apr 30, 2013
- Completion
- Apr 30, 2013
- Last update posted
- Nov 12, 2015
2011 – 2013
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ. of California San Francisco NICHD CRS (5091) | San Francisco | California | 94117 | — |
| Children's National Med. Ctr. Washington DC NICHD CRS (5015) | Washington D.C. | District of Columbia | 20010 | — |
| University of Florida (5051) | Jacksonville | Florida | 32209 | — |
| Univ of Miami Pediatric/Perinatal HIV/AIDS (4201) | Miami | Florida | 33136 | — |
| Chicago Children's CRS (4001) | Chicago | Illinois | 60614 | — |
| Johns Hopkins University NICHD CRS (5092) | Baltimore | Maryland | 21287 | — |
| Metropolitan Hospital (5003) | New York | New York | 10029 | — |
| SUNY Stony Brook NICHD CRS (5040) | Stony Brook | New York | 11794 | — |
| Bronx-Lebanon Hospital (6901) | The Bronx | New York | 10457 | — |
| DUMC Ped. CRS (4701) | Durham | North Carolina | 27710-3499 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01338025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01338025 live on ClinicalTrials.gov.